Who is sponsoring NCT05599854?

NCT05599854 is sponsored by Assiut University.

What drugs are being tested in NCT05599854?

Interventions in NCT05599854: vitrectomy and silicone oil injection.

What condition does NCT05599854 study?

NCT05599854 studies ASOCT Changes After Vitrectomy and Silicone Oil Injection.

Is NCT05599854 still recruiting?

NCT05599854 is currently status unknown. Last updated 31 October 2022.

Last reviewed 2022-10-31 · How we verify

NCT05599854

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Short-term Anterior Segment Changes After Pars Plana Vitrectomy (PPV) and Silicone Oil (SO) Tamponade, Anterior Segment OCT (AS-OCT) Study.

Status unknown NA Last updated 31 October 2022

What this trial tests

NA trial testing vitrectomy and silicone oil injection in ASOCT Changes After Vitrectomy and Silicone Oil Injection in 30 participants. Status unknown.

Timeline

1 November 2022

Primary endpoint
1 October 2025

1 December 2025

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	double
Primary purpose	screening
Enrollment	30
Start date	1 November 2022
Primary completion	1 October 2025
Estimated completion	1 December 2025

Drugs / interventions tested

vitrectomy and silicone oil injection

Conditions studied

ASOCT Changes After Vitrectomy and Silicone Oil Injection — all drugs for ASOCT Changes After Vitrectomy and Silicone Oil Injection →

Sponsor

Assiut University

Who can join

Eligibility, any sex, with ASOCT Changes After Vitrectomy and Silicone Oil Injection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of our study is to utilize AS-OCT to analyze the anterior segment morphological changes in the early postoperative period of patients who will undergo PPV with silicone oil injection.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05599854 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 31 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05599854.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing